Ticker Details
Sagimet Biosciences Inc. Series A
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$637.13M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 5.23%
Avg Daily Range (30 D):	$0.29 | 3.58%
Avg Daily Range (90 D):	$0.29 | 3.98%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.08M
Avg Daily Volume (90 D):	1.44M

Trade Size
Avg Trade Size (Sh.):	118
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	141
Avg Institutional Trade:	$1.65M
Avg Institutional Trade (30 D):	$.93M
Avg Institutional Trade (90 D):	$1.97M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.28M
Avg Closing Trade (30 D):	$.94M
Avg Closing Trade (90 D):	$2.21M
Avg Closing Volume:	329.82K

News

Jun 29, 2026 @ 11:00 AM Sagimet Biosciences Joins the Russell 2000® and... Source: Na

Jun 23, 2026 @ 12:49 AM Sagimet Biosciences Announces Participation in Upc... Source: Na

Apr 20, 2026 @ 11:00 AM Sagimet Biosciences Announces Appointment of Andre... Source: Na

Apr 6, 2026 @ 11:00 AM Sagimet Biosciences Announces Poster and Oral Pres... Source: Na

Feb 5, 2026 @ 12:00 PM Sagimet Biosciences Announces Participation in Two... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.26	$-.33	$-.3
Diluted EPS	$-.26	$-.33	$-.3
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-13.95M	$-10.65M	$-9.57M
Operating Income / Loss	$-15.82M	$-11.71M	$-10.77M
Cost of Revenue
Net Cash Flow	$130.88M	$M	$2.53M
PE Ratio